Tissue Regenix secures additional coverage in the US for DermaPure

Writer, Stock Market Wire
Thursday, April 4, 2019 - 07:48

Tissue Regenix secured additional coverage with a US Group Purchasing Organization (GPO) for the use of DermaPure, a decellularized allograft dermis.

The company said the additional coverage will open up access to 1,500 hospitals and 32,500 alternative care providers, primarily in the south eastern region of the US, bolstering the commercial opportunity in Florida, the second largest state with regard to the use of biological tissues.

Tissue Regenix said this builds on its contracts with the two largest GPOs in the US, Premier, and Vizient.

The addition of this new agreement increases potential DermaPure availability into 95% of institutions that purchase via large GPO networks, allowing patients and physicians potential to access clinical and health economic benefits provided by DermaPure.


Related content

Tissue Regenix secures $20m in loan facilities

Regenerative medical devices company Tissue Regenix Group said some of its subsidiaries had agreed with MidCap Financial Trust to access a revolving credit facility and...

Tue, 04/06/2019 - 07:31


Tissue Regenix CEO to return to full-time duties after medical treatment

Regenerative medical devices company Tissue Regenix Group said chief executive Steve Couldwell would return to full time duties during June.

Couldwell had taken a leave...

Tue, 21/05/2019 - 08:25


Tissue Regenix moves closer to profitability after revenue jumps

Regenerative medical devices company Tissue Regenix Group said it expected to move closer to its goal of generating 'sustainable profitability' in 2019 after it more...

Mon, 04/02/2019 - 14:17


Tissue Regenix signs European distribution agreement with Arthrex

Regenerative medical devices company Tissue Regenix Group said it had entered into an agreement allowing Arthrex to distribute its BioRinse bone portfolio throughout Europe, with...

Tue, 13/11/2018 - 09:19


Tissue Regenix confirms new CFO appointment

Manchester-based medical devices company Tissue Regenix Group confirmed that Gareth Jones had officially taken up the role of chief financial officer.

His appointment had been...

Mon, 29/10/2018 - 07:54